Terms ending in 2033
Every in-force patent on Biogen Idec MA Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,676,849 | Enhancement of Transport of Therapeutic Molecules Across the Blood Brain Barrier In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 11,286,528 | Methods of Reducing Immunogenicity Against Factor VIII in Individuals Undergoing Factor VIII Therapy In force · High confidence | Bioverativ Therapeutics Inc. | In force | High confidence | |
| US 9,233,107 | Compositions and Methods for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 9,567,391 | JCV Neutralizing Antibodies In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 9,567,392 | JCV Neutralizing Antibodies In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 9,562,252 | Methods of Preventing and Removing Trisulfide Bonds In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 10,421,798 | Factor VIII Compositions and Methods of Making and Using Same In force · High confidence | Bioverativ Therapeutics Inc. | In force | High confidence | |
| US 9,738,707 | Heterodimeric FC Regions, Binding Molecules Comprising Same, and Methods Relating Thereto In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 10,618,887 | Pyrimidinyl Tyrosine Kinase Inhibitors In force · High confidence | Viracta Therapeutics, Inc. | In force | High confidence | |
| US 10,023,628 | Cell Line Expressing Single Chain Factor VIII Polypeptides and Uses Thereof In force · High confidence | Bioverativ Therapeutics Inc. | In force | High confidence | |
| 3 more term ends in 2033 · Pro | |||||
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
2 of these are in force and held by Biogen Idec MA Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.